+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Pharmaceutical Vials Market - Distribution by Type of Fabrication Material Used, Sterilization Status and Key Geographies – Industry Trends and Global Forecasts, 2021-2030

  • PDF Icon

    Report

  • 220 Pages
  • September 2021
  • Region: Global
  • Roots Analysis
  • ID: 5470689

Over the years, advances in drug / therapy development processes have led the pharmaceutical industry to gradually shift from a one-drug treats all model to a more personalized approach of treatment. The growing complexity of modern pharmacological interventions, such as monoclonal antibodies, and cell and gene therapies, has further prompted the drug developers to develop or identify specialized fill / finish and packaging alternatives that are capable of catering to the specific needs of such novel products. Pharmaceutical packaging, owing to the fact that it is in immediate contact with the drug / therapy formulation, plays a vital role in preserving the identity, quality and integrity of the packaged medicinal product. Although there are various types of primary packaging containers, including ampoules, cartridges and syringes, available in the market for various types of drug formulations, pharmaceutical vials have been observed to be the preferred choice of drug developers, owing to the fact that they provide high container-closure integrity.


Despite being the most preferred packaging system, traditional vials are often associated with certain challenges, including chances of breakage under extreme conditions, absence of relevant information (serial or batch number) on the package and potential to delaminate. As a result, several pharmaceutical vial manufacturers are exploring novel techniques to overcome the aforementioned challenges associated with conventional pharmaceutical vials in order to create better packaging solutions. Examples of some advancements in this domain include the use of serialization techniques (to avoid drug counterfeiting), development of numerous coating materials (to prevent delamination and pH imbalance) and the adoption of smart drug delivery technologies (to improve patient compliance).


Furthermore, pre-sterilized / ready-to-use (RTU) pharmaceutical vials have emerged as a promising alternative to conventional pharmaceutical vials, adding significant value to streamline pharmaceutical fill / finish operations. It is worth noting that these innovations have significantly helped in optimizing costs, easing the filling process and expediting production timelines. Moreover, it enables the pharmaceutical players to overcome regulatory challenges, as well as build a sustainable competitive edge in the market. In addition, due to the unprecedent outbreak of the COVID-19 pandemic, the demand for parenteral formulations has increased significantly, therefore providing lucrative opportunities for pharmaceutical companies engaged in the development of safe and superior quality vials. In the future, the high demand for parenteral formulations and increase in vaccination campaigns are likely to drive the growth of the pharmaceutical vials market.


Report Scope

The “Global Pharmaceutical Vials Market - Distribution by Type of Fabrication Material Used (Glass and Plastic), Sterilization Status (Pre-sterilized and Unsterilized) and Key Geographies (North America, Europe, Asia Pacific, Latin America, Middle East and North Africa and Rest of the World) – Industry Trends and Global Forecasts, 2021-2030” report features an extensive study of the current market landscape and future potential of pharmaceutical vials over the next decade. The study features an in-depth analysis of the key drivers and trends related to this domain. Amongst other elements, the report includes:


  • A detailed assessment of the current market landscape of pharmaceutical vials, featuring information on the type of fabrication material used for container (glass and plastic), type of fabrication material used for closure (rubber, plastic and metal), volume of vial (less than 50 ml, 50 ml to 100 ml and more than 100 ml), type of vial cap (screw cap, crimp cap and snap cap), sterilization status (pre-sterilized and unsterilized), type of product (untreated and treated), compatible drug class (biologics and small molecules) and type of formulation stored (liquid, powder and solid). In addition, the chapter includes analysis related to pharmaceutical vial manufacturers based on various parameters, including year of establishment, company size, location of headquarters and key players (in terms of number of products).
  • A competitiveness analysis of pharmaceutical vial manufacturers, segmented into four categories, namely small (1-50 employees), mid-sized companies (51-500 employees), and large (501-1,000 employees) and very large companies (more than 1,000 employees). Within the peer group, companies were ranked based on various relevant parameters, such as supplier power (based on the experience / expertise of the manufacturer) and key product specifications (type of fabrication material used, type of vial cap, sterilization status, type of product, compatible drug class and type of formulation stored).
  • Elaborate profiles of prominent players engaged in the development of pharmaceutical vials, based in North America, Europe and Asia Pacific. Each profile features a brief overview of the company, details related to its financials (if available), product portfolio, recent developments and an informed future outlook.
  • An analysis of the partnerships that have been inked by stakeholders engaged in this domain, during the period 2015-2021 (till September), covering acquisitions, product / technology integration agreements, supply agreements, asset acquisitions, distribution agreements, product / technology development agreements, product / technology licensing agreements, and other related agreements. Further, the partnership activity in this domain has been analyzed based on various parameters, such as year of partnership, type of fabrication material involved, sterilization status, type of partners and regional distribution of the collaborations.
  • An elaborate discussion on the key trends (such as the advent of personalized / targeted therapies, shift towards more flexible packaging, rise of modular manufacturing facilities and advancement in robotic packaging solutions) that are likely to have an impact on the future adoption of innovative primary packaging systems. It also features a harvey ball analysis, highlighting the relative effect of each trend on the overall pharmaceutical packaging industry.
  • An in-depth analysis to estimate the current and future demand for pharmaceutical vials based on various relevant parameters, such as type of fabrication material used, sterilization status and regions, for the period 2021-2030.
  • A case study on the use of robotic machinery in pharmaceutical manufacturing and fill / finish operations, highlighting the advantages of using automation / automated technologies in such processes. Further, it presents the profiles of industry players that provide such equipment for aseptic processing of pharmaceuticals. 
  • A case study on pre-sterilized / RTU pharmaceutical vials that are available nowadays. In addition, it provides information on the various sterilization techniques used for primary packaging materials and the advantages of RTU container-closure systems. 

One of the key objectives of the report was to estimate the existing market size and identify potential growth opportunities for pharmaceutical vials over the coming decade. Based on several parameters, such as target consumer segments, region specific adoption rates and expected prices of these products, the report has provided an informed estimate on the likely evolution of the market over the period 2021-2030.


The report provides sales forecasts for the overall pharmaceutical vials market, wherein both the current and upcoming opportunity is segmented across [A] type of fabrication material used (glass and plastic), [B] sterilization status (pre-sterilized and unsterilized) and [C] key geographies (North America, Europe, Asia Pacific, Middle East and North Africa, Latin America and Rest of the world). In order to account for future uncertainties and to add robustness to the model, the report provides three market forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry’s growth.


The opinions and insights presented in this study were influenced by discussions conducted with multiple stakeholders in this domain. The report features detailed transcripts of interviews held with the following individuals:


  • Julien Marechal (Business Development and Technology Director, Aseptic Technologies)
  • Konstantin Kazarian (Former Project Manager of Business Development, PYRAMID Laboratories)
  • Lawrence Ganti (President, SiO2 Materials Science)

Key Questions Answered

  • Who are the leading players engaged in the manufacturing of pharmaceutical vials?
  • What is the relative competitiveness of different pharmaceutical vial manufacturers?
  • What type of partnership models are commonly adopted by industry stakeholders engaged in this industry? 
  • What is the current, global demand for pharmaceutical vials?
  • What are the emerging trends related to pharmaceutical primary packaging?
  • What are the factors that are likely to influence the growth of the pharmaceutical vials market?
  • How is the current and future opportunity likely to be distributed across key market segments?

Table of Contents

1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Key Questions Answered
1.4. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Chapter Overview
3.2. Pharmaceutical Packaging
3.2.1. Need for Pharmaceutical Packaging
3.2.2. Types of Pharmaceutical Packaging
3.3. Pharmaceutical Vials
3.3.1. Types of Fabrication Materials Used for Vials
3.3.1.1. Glass Vials
3.3.1.2. Plastic Vials
3.3.2. Vial Caps
3.4 Innovation in Pharmaceutical Vials


4. MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Pharmaceutical Vials: Overall Market Landscape
4.2.1. Analysis by Type of Fabrication Material Used (Container)
4.2.2. Analysis by Type of Fabrication Material Used (Closure)
4.2.3. Analysis by Volume of Vial
4.2.4. Analysis by Type of Vial Cap
4.2.5. Analysis by Sterilization Status
4.2.6. Analysis by Type of Product
4.2.7. Analysis by Compatible Drug Class
4.2.8. Analysis by Type of Formulation Stored


4.3. Pharmaceutical Vials: List of Manufacturers
4.3.1. Analysis by Year of Establishment
4.3.2. Analysis by Company Size
4.3.3. Analysis by Location of Headquarters
4.3.4. Leading Manufacturers: Analysis by Number of Products


5. COMPANY COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Assumptions and Key Parameters
5.3. Methodology
5.4. Pharmaceutical Vials: Company Competitiveness Analysis
5.4.1. Company Competitiveness: Small Manufacturers
5.4.2. Company Competitiveness: Mid-sized Manufacturers
5.4.3. Company Competitiveness: Large Manufacturers
5.4.4. Company Competitiveness: Very Large Manufacturers


6. COMPANY PROFILES: PHARMACEUTICAL VIAL MANUFACTURERS IN NORTH AMERICA
6.1. Chapter Overview
6.2. Corning
6.2.1. Company Overview
6.2.2. Financial Information
6.2.3. Pharmaceutical Vials Portfolio
6.2.4. Recent Developments and Future Outlook


6.3. DWK Life Sciences
6.3.1. Company Overview
6.3.2. Pharmaceutical Vials Portfolio
6.3.3. Recent Developments and Future Outlook


6.4. Pacific Vial Manufacturing
6.4.1. Company Overview
6.4.2. Pharmaceutical Vials Portfolio
6.4.3. Recent Developments and Future Outlook


6.5. Thermo Fischer Scientific
6.5.1. Company Overview
6.5.2. Financial Information
6.5.3. Pharmaceutical Vials Portfolio
6.5.4. Recent Developments and Future Outlook


6.6. Worldwide Glass Resources
6.6.1. Company Overview
6.6.2. Pharmaceutical Vials Portfolio
6.6.3. Recent Developments and Future Outlook


7. COMPANY PROFILES: PHARMACEUTICAL VIAL MANUFACTURERS IN EUROPE
7.1. Chapter Overview
7.2. Gerresheimer
7.2.1. Company Overview
7.2.2. Financial Information
7.2.3. Pharmaceutical Vials Portfolio
7.2.4. Recent Developments and Future Outlook


7.3. Origin Pharma Packaging
7.3.1. Company Overview
7.3.2. Pharmaceutical Vials Portfolio
7.3.3. Recent Developments and Future Outlook


7.4. SCHOTT
7.4.1. Company Overview
7.4.2. Financial Information
7.4.3. Pharmaceutical Vials Portfolio
7.4.4. Recent Developments and Future Outlook


7.5. SGD Pharma
7.5.1. Company Overview
7.5.2. Financial Information
7.5.3. Pharmaceutical Vials Portfolio
7.5.4. Recent Developments and Future Outlook


7.6. Stevanato Group
7.6.1. Company Overview
7.6.2. Pharmaceutical Vials Portfolio
7.6.3. Recent Developments and Future Outlook


8. COMPANY PROFILES: PHARMACEUTICAL VIAL MANUFACTURERS IN ASIA PACIFIC
8.1. Chongqing Zhengchuan Pharmaceutical Packaging
8.1.1. Company Overview
8.1.2. Pharmaceutical Vials Portfolio
8.1.3. Recent Developments and Future Outlook


8.2. DANYANG XIANGHE PHARMACEUTICAL PACKAGING
8.2.1. Company Overview
8.2.2. Pharmaceutical Vials Portfolio
8.2.3. Recent Developments and Future Outlook


8.3. Ningbo Zhengli Pharmaceutical Packaging
8.3.1. Company Overview
8.3.2. Pharmaceutical Vials Portfolio
8.3.3. Recent Developments and Future Outlook


8.4. Nipro
8.4.1. Company Overview
8.4.2. Financial Information
8.4.3. Pharmaceutical Vials Portfolio
8.4.4. Recent Developments and Future Outlook


8.5. Shandong Pharmaceutical Glass
8.5.1. Company Overview
8.5.2. Pharmaceutical Vials Portfolio
8.5.3. Recent Developments and Future Outlook


9. PARTNERSHIPS AND COLLABORATIONS
9.1. Chapter Overview
9.2. Partnership Models
9.3. Pharmaceutical Vials: List of Partnerships and Collaborations
9.3.1. Analysis by Year of Partnership
9.3.2. Analysis by Type of Partnership
9.3.3. Analysis by Year and Type of Partnership
9.3.4. Analysis by Type of Fabrication Material Used
9.3.5. Analysis by Sterilization Status
9.3.6. Analysis by Type of Partner
9.3.7. Most Active Players: Analysis by Number of Partnerships
9.3.8. Analysis by Geography
9.3.8.1. Region-wise Distribution
9.3.8.2. Country-wise Distribution


10. UPCOMING TRENDS IN PHARMACEUTICAL PACKAGING
10.1. Chapter Overview
10.2. Preference for Self-medication of Drugs, Through the Use of Modern Drug Delivery Devices
10.3. Development of Improved Packaging Components and Efforts to Optimize Manufacturing Costs
10.4. Availability of Modular Facilities
10.5. Growing Demand and Preference for Personalized Therapies
10.6. Rise in Provisions for Automating Fill / Finish Operations
10.7. Surge in Partnership Activity
10.8. Increase in Initiatives Undertaken by Industry Stakeholders in Developing Regions
10.9. Concluding Remarks


11. DEMAND ANALYSIS
11.1. Chapter Overview
11.2. Scope and Methodology
11.3. Global Demand for Pharmaceutical Vials, 2021-2030
11.3.1. Analysis by Type of Fabrication Material Used
11.3.1.1. Global Demand for Pharmaceutical Glass Vials, 2021-2030
11.3.1.2. Global Demand for Pharmaceutical Plastic Vials, 2021-2030


11.3.2. Analysis by Sterilization Status
11.3.2.1. Global Demand for Unsterilized Pharmaceutical Vials, 2021-2030
11.3.2.2. Global Demand for Pre-sterilized Pharmaceutical Vials, 2021-2030


11.3.3. Analysis by Geography
11.3.3.1. Demand for Pharmaceutical Vials in North America, 2021-2030
11.3.3.2. Demand for Pharmaceutical Vials in Europe, 2021-2030
11.3.3.3. Demand for Pharmaceutical Vials in Asia Pacific, 2021-2030
11.3.3.4. Demand for Pharmaceutical Vials in Middle East and North Africa, 2021-2030
11.3.3.5. Demand for Pharmaceutical Vials in Latin America, 2021-2030
11.3.3.6. Demand for Pharmaceutical Vials in Rest of the World, 2021-2030


11.4. Concluding Remarks


12. MARKET FORECAST AND OPPORTUNITY ANALYSIS
12.1. Chapter Overview
12.2. Forecast Methodology and Key Assumptions
12.3. Global Pharmaceutical Vials Market, 2021-2030
12.3.1. Pharmaceutical Vials Market, 2021 and 2030: Distribution by Type of Fabrication Material Used
12.3.1.1. Pharmaceutical Glass Vials Market, 2021-2030
12.3.1.2. Pharmaceutical Plastic Vials Market, 2021-2030


12.3.2. Pharmaceutical Vials Market, 2021 and 2030: Distribution by Sterilization Status
12.3.2.1. Unsterilized Pharmaceutical Vials Market, 2021-2030
12.3.2.2. Pre-sterilized Pharmaceutical Vials Market, 2021-2030


12.3.3. Pharmaceutical Vials Market, 2021 and 2030: Distribution by Geography
12.3.3.1. Pharmaceutical Vials Market in North America, 2021-2030
12.3.3.2. Pharmaceutical Vials Market in Europe, 2021-2030
12.3.3.3. Pharmaceutical Vials Market in Asia Pacific, 2021-2030
12.3.3.4. Pharmaceutical Vials Market in Middle East and North Africa, 2021-2030
12.3.3.5. Pharmaceutical Vials Market in Latin America, 2021-2030
12.3.3.6. Pharmaceutical Vials Market in Rest of the World, 2021-2030


13. CASE STUDY: ROBOTS IN PHARMACEUTICAL PACKAGING
13.1. Chapter Overview
13.2. Role of Robots in the Pharmaceutical Industry
13.2.1. Key Considerations for Selecting a Robotic System
13.2.2. Advantages of Robotic Systems
13.2.3. Disadvantages of Robotic Systems


13.3. Companies Providing Robots for Use in the Pharmaceutical Industry
13.4. Companies Providing Equipment Integrated with Robotic Systems for Pharmaceutical Packaging
13.4.1. Aseptic Technologies
13.4.2. AST
13.4.3. Bosch Packaging Technology
13.4.4. Dara Pharmaceutical Packaging
13.4.5. Fedegari Group
13.4.6. IMA
13.4.7. Steriline
13.4.8. Vanrx Pharmasystems


14. CASE STUDY: PRE-STERILIZED / READY-TO-USE PHARMACEUTICAL VIALS
14.1. Chapter Overview
14.2. Pharmaceutical Packaging and Filling
14.3. Limitations of Traditional Primary Packaging
14.4. Ready-to-Use Primary Packaging
14.4.1. Sterilization of Primary Packaging Material
14.4.1.1. Sterilization Techniques
14.4.2. Advantages of Ready-to-Use Primary Packaging
14.4.3. Cost Saving Opportunities associated with Ready-To-Use Primary Packaging
14.4.4. Current Demand for Ready-To-Use Primary Packaging and Key Enablers
14.4.5. List of Pre-Sterilized / Ready-to-Use Pharmaceutical Vials
14.5. Concluding Remarks


15. CONCLUDING REMARKS
16. EXECUTIVE INSIGHTS
16.1. Chapter Overview
16.2. Aseptic Technologies
16.2.1. Company Snapshot
16.2.2. Interview Transcript: Julien Marechal, Business Development and Technology Director


16.3. PYRAMID Laboratories
16.3.1. Company Snapshot
16.3.2. Interview Transcript: Konstantin Kazarian, Former Project Manager of Business Development


16.4. SiO2 Materials Science
16.4.1. Company Snapshot
16.4.2. Interview Transcript: Lawrence Ganti, SiO2 Materials Science


17. APPENDIX 1: TABULATED DATA
List Of Figures

Figure 3.1 Advantages of Pharmaceutical Packaging
Figure 3.2 Types of Pharmaceutical Packaging
Figure 3.3 Advantages of Glass Vials
Figure 3.4 Innovation in Pharmaceutical Packaging and Value Chain
Figure 4.1 Pharmaceutical Vials: Distribution by Type of Fabrication Material Used (Container)
Figure 4.2 Pharmaceutical Vials: Distribution by Type of Fabrication Material Used (Closure)
Figure 4.3 Pharmaceutical Vials: Distribution by Volume of Vial
Figure 4.4 Pharmaceutical Vials: Distribution by Type of Vial Cap
Figure 4.5 Pharmaceutical Vials: Distribution by Sterilization Status
Figure 4.6 Pharmaceutical Vials: Distribution by Type of Product
Figure 4.7 Pharmaceutical Vials: Distribution by Compatible Drug Class
Figure 4.8 Pharmaceutical Vials: Distribution by Type of Formulation Stored
Figure 4.9 Pharmaceutical Vials Manufacturers: Distribution by Year of Establishment
Figure 4.10 Pharmaceutical Vials Manufacturers: Distribution by Company Size
Figure 4.11 Pharmaceutical Vials Manufacturers: Distribution by Location of Headquarters
Figure 4.12 Leading Manufacturers: Distribution by Number of Products
Figure 5.1 Company Competitiveness Analysis: Small Manufacturers
Figure 5.2 Company Competitiveness Analysis: Mid-sized Manufacturers
Figure 5.3 Company Competitiveness Analysis: Large Manufacturers
Figure 5.4 Company Competitiveness Analysis: Very Large Manufacturers
Figure 6.1 Corning: Annual Revenues, 2016-H1 2021 (USD Billion)
Figure 6.2 Thermo Fisher Scientific: Annual Revenues, 2016-H1 2021 (USD Billion)
Figure 7.1 Gerresheimer: Annual Revenues, 2016-Q1 2021 (EUR Billion)
Figure 7.2 SCHOTT: Annual Revenues, 2016-2020 (EUR Billion)
Figure 8.1 Nipro: Annual Revenues, 2016-2020 (JPY Billion)
Figure 9.1 Partnerships and Collaborations: Cumulative Year-wise Trend, 2015-2021
Figure 9.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 9.3 Partnerships and Collaborations: Year-wise Trend by Type of Partnership
Figure 9.4 Partnerships and Collaborations: Distribution by Type of Fabrication Material Used
Figure 9.5 Partnerships and Collaborations: Year-wise Trend by Type of Fabrication Material Used
Figure 9.6 Partnerships and Collaborations: Distribution by Sterilization Status
Figure 9.7 Partnerships and Collaborations: Year-wise Trend by Sterilization Status
Figure 9.8 Partnerships and Collaborations: Distribution by Analysis by Type of Partner
Figure 9.9 Partnerships and Collaborations: Year-wise Trend by Analysis by Type of Partner
Figure 9.10 Most Active Players: Distribution by Number of Partnerships
Figure 9.11 Partnerships and Collaborations: Distribution by Region (Continent-wise)
Figure 9.12 Partnerships and Collaborations: Distribution by Region (Country-wise)
Figure 10.1 Upcoming Trends Related to Pharmaceutical Packaging
Figure 10.2 Future Growth Opportunities of Innovative Pharmaceutical Packaging based on Recent Trends
Figure 11.1 Global Demand for Pharmaceutical Vials, 2021-2030 (Billion Units)
Figure 11.2 Global Demand for Pharmaceutical Vials: Distribution by Type of Fabrication Material Used, 2021 and 2030 (Billion Units)
Figure 11.3 Global Demand for Pharmaceutical Glass Vials, 2021-2030 (Billion Units)
Figure 11.4 Global Demand for Pharmaceutical Plastic Vials, 2021-2030 (Billion Units)
Figure 11.5 Global Demand for Pharmaceutical Vials: Distribution by Sterilization Status, 2021 and 2030 (Billion Units)
Figure 11.6 Global Demand for Unsterilized Pharmaceutical Vials, 2021-2030 (Billion Units)
Figure 11.7 Global Demand for Pre-sterilized Pharmaceutical Vials, 2021-2030 (Billion Units)
Figure 11.8 Global Demand for Pharmaceutical Vials: Distribution by Geography, 2021 and 2030
Figure 11.9 Demand for Pharmaceutical Vials in North America, 2021-2030 (Billion Units)
Figure 11.10 Demand for Pharmaceutical Vials in Europe, 2021-2030 (Billion Units)
Figure 11.11 Demand for Pharmaceutical Vials in Asia Pacific, 2021-2030 (Billion Units)
Figure 11.12 Demand for Pharmaceutical Vials in Middle East and North Africa, 2021-2030 (Billion Units)
Figure 11.13 Demand for Pharmaceutical Vials in Latin America, 2021-2030 (Billion Units)
Figure 11.14 Demand for Pharmaceutical Vials in Rest of the World, 2021-2030 (Billion Units)
Figure 12.1 Global Pharmaceutical Vials Market, 2021-2030 (USD Billion)
Figure 12.2 Pharmaceutical Vials: Likely Growth Scenarios
Figure 12.3 Pharmaceutical Vials Market, 2021 and 2030: Distribution by Type of Fabrication Material Used (USD Billion)
Figure 12.4 Pharmaceutical Glass Vials Market, 2021-2030 (USD Billion)
Figure 12.5 Pharmaceutical Plastic Vials Market, 2021-2030 (USD Billion)
Figure 12.6 Pharmaceutical Vials Market, 2021 and 2030: Distribution by Sterilization Status (USD Billion)
Figure 12.7 Unsterilized Pharmaceutical Vials Market, 2021-2030 (USD Billion)
Figure 12.8 Pre-sterilized Pharmaceutical Vials Market, 2021-2030 (USD Billion)
Figure 12.9 Pharmaceutical Vials Market, 2021 and 2030: Distribution by Geography (USD Billion)
Figure 12.10 Pharmaceutical Vials Market in North America, 2021-2030 (USD Billion)
Figure 12.11 Pharmaceutical Vials Market in Europe, 2021-2030 (USD Billion)
Figure 12.12 Pharmaceutical Vials Market in Asia-Pacific, 2021-2030 (USD Billion)
Figure 12.13 Pharmaceutical Vials Market in Middle East and North Africa, 2021-2030 (USD Billion)
Figure 12.14 Pharmaceutical Vials Market in Latin America, 2021-2030 (USD Billion)
Figure 12.15 Pharmaceutical Vials Market in Rest of the World, 2021-2030 (USD Billion)
Figure 13.1 Key Considerations for Selecting a Robotic System
Figure 13.2 Advantages Associated with Use of Robotic Systems in Pharmaceutical Manufacturing
Figure 14.1 Traditional Aseptic Pharmaceutical Filling
Figure 14.2 Ready-to-Use Enabled Flexible, Aseptic Processing
Figure 14.3 Advantages of Ready-to-Use Platform
Figure 14.4 Cost Comparison of Ready-to-Use and Conventional Container Systems
Figure 14.5 Drivers of Ready-to-Use Platform
Figure 16.1 Concluding Remarks: Overall Market Landscape
Figure 16.2 Concluding Remarks: Partnerships and Collaborations
Figure 16.3 Concluding Remarks: Global Demand for Pharmaceutical Vials
Figure 16.4 Concluding Remarks: Market Forecast

List Of Tables

Table 3.1 Difference between Tubular and Moulded Glass Vials
Table 4.1 Pharmaceutical Vials: List of Products
Table 4.2 Pharmaceutical Vials: List of Manufacturers
Table 6.1 Leading Manufacturers of Pharmaceutical Vials in North America
Table 6.2 Corning: Company Snapshot
Table 6.3 Corning: Pharmaceutical Vials
Table 6.4 Corning: Recent Developments and Future Outlook
Table 6.5 DWK Life Sciences: Company Snapshot
Table 6.6 DWK Life Sciences: Pharmaceutical Vials
Table 6.7 DWK Life Sciences: Recent Developments and Future Outlook
Table 6.8 Pacific Vial Manufacturing: Company Snapshot
Table 6.9 Pacific Vial Manufacturing: Pharmaceutical Vials
Table 6.10 Thermo Fisher Scientific: Company Snapshot
Table 6.11 Thermo Fisher Scientific: Pharmaceutical Vials
Table 6.12 Thermo Fisher Scientific: Recent Developments and Future Outlook
Table 6.13 Worldwide Glass Resources: Company Snapshot
Table 6.14 Worldwide Glass Resources: Pharmaceutical Vials
Table 7.1 Leading Manufacturers of Pharmaceutical Vials in Europe
Table 7.2 Gerresheimer: Company Snapshot
Table 7.3 Gerresheimer: Pharmaceutical Vials
Table 7.4 Gerresheimer: Recent Developments and Future Outlook
Table 7.5 Origin Pharma Packaging: Company Snapshot
Table 7.6 Origin Pharma Packaging: Pharmaceutical Vials
Table 7.7 SCHOTT: Company Snapshot
Table 7.8 SCHOTT: Pharmaceutical Vials
Table 7.9 SCHOTT: Recent Developments and Future Outlook
Table 7.10 SGD Pharma: Company Snapshot
Table 7.11 SGD Pharma: Pharmaceutical Vials
Table 7.12 SGD Pharma: Recent Developments and Future Outlook
Table 7.13 Stevanato Group: Company Snapshot
Table 7.14 Stevanato Group: Pharmaceutical Vials
Table 7.15 Stevanato Group: Recent Developments and Future Outlook
Table 8.1 Leading Manufacturers of Pharmaceutical Vials in Asia Pacific
Table 8.2 Chongqing Zhengchuan Pharmaceutical Packaging: Company Snapshot
Table 8.3 Chongqing Zhengchuan Pharmaceutical Packaging: Pharmaceutical Vials
Table 8.4 DANYANG XIANGHE PHARMACEUTICAL PACKAGING: Company Snapshot
Table 8.5 DANYANG XIANGHE PHARMACEUTICAL PACKAGING: Pharmaceutical Vials
Table 8.6 Ningbo Zhengli Pharmaceutical Packaging: Company Snapshot
Table 8.7 Ningbo Zhengli Pharmaceutical Packaging: Pharmaceutical Vials
Table 8.8 Ningbo Zhengli Pharmaceutical Packaging: Recent Developments and Future Outlook
Table 8.9 Nipro: Company Snapshot
Table 8.10 Nipro: Pharmaceutical Vials
Table 8.11 Nipro: Recent Developments and Future Outlook
Table 8.12 Shandong Pharmaceutical Glass: Company Snapshot
Table 8.13 Shandong Pharmaceutical Glass: Pharmaceutical Vials
Table 9.1 Pharmaceutical Vials: Partnerships and Collaborations, 2015-2021
Table 12.1 Tiered Pricing Structure of Prices of Pharmaceutical Vials across Different Geographies
Table 13.1 List of Pharmaceutical Robotics Manufacturers
Table 13.2 Aseptic Technologies: Company Overview
Table 13.3 Aseptic Technologies: Key Specifications of Crystal L1 Robot Line
Table 13.4 Aseptic Technologies: Key Specifications of Crystal SL1 Robot Line
Table 13.5 AST: Company Overview
Table 13.6 AST: Key Specifications of ASEPTiCell
Table 13.7 AST: Key Specifications of GENiSYS R
Table 13.8 AST: Key Specifications of GENiSYS C
Table 13.9 AST: Key Specifications of GENiSYS Lab
Table 13.10 Bosch Packaging Technology: Company Overview
Table 13.11 Bosch Packaging Technology: Key Specifications of ATO
Table 13.12 Dara Pharmaceutical Equipment: Company Overview
Table 13.13 Dara Pharmaceutical Equipment: Key Specifications of SYX-E Cartridge + RABS
Table 13.14 Fedegari Group: Company Overview
Table 13.15 Fedegari Group: Key Specifications of Fedegari Isolator
Table 13.16 IMA: Company Overview
Table 13.17 IMA: Key Specifications of INJECTA
Table 13.18 IMA: Key Specifications of STERI LIF3
Table 13.19 Steriline: Company Overview
Table 13.20 Steriline: Key Specifications of Robotic Nest Filling Machine
Table 13.21 Steriline: Key Specifications of Robotic Vial Filling Machine
Table 13.22 Steriline: Key Specifications of Robotic Vial Capping Machine
Table 13.23 Vanrx Pharmasystems: Company Overview
Table 13.24 Vanrx Pharmasystems: Key Specifications of Microcell Vial Filler
Table 13.25 Vanrx Pharmasystems: Key Specifications of SA25 Aseptic Filling Workcell
Table 14.1 Compatibility of Polymers with Ethylene Oxide Sterilization
Table 14.2 Advantages and Disadvantages of Different Sterilization Techniques
Table 14.3 List of Pre-sterilized / Ready-to-Use Pharmaceutical Vials
Table 16.1 Aseptic Technologies: Company Snapshot
Table 16.2 PYRAMID Laboratories: Company Snapshot
Table 16.3 SiO2 Materials Science: Company Snapshot
Table 17.1 Pharmaceutical Vials: Distribution by Type of Fabrication Material Used (Container)
Table 17.2 Pharmaceutical Vials: Distribution by Type of Fabrication Material Used (Closure)
Table 17.3 Pharmaceutical Vials: Distribution by Volume of Vial
Table 17.4 Pharmaceutical Vials: Distribution by Type of Vial Cap
Table 17.5 Pharmaceutical Vials: Distribution by Sterilization Status
Table 17.6 Pharmaceutical Vials: Distribution by Type of Product
Table 17.7 Pharmaceutical Vials: Distribution by Compatible Drug Class
Table 17.8 Pharmaceutical Vials: Distribution by Type of Formulation Stored
Table 17.9 Pharmaceutical Vials Manufacturers: Distribution by Year of Establishment
Table 17.10 Pharmaceutical Vials Manufacturers: Distribution by Company Size
Table 17.11 Pharmaceutical Vials Manufacturers: Distribution by Location of Headquarters
Table 17.12 Leading Manufacturers: Distribution by Number of Products
Table 17.13 Corning: Annual Revenues, 2016-H1 2021 (USD Billion)
Table 17.14 Thermo Fisher Scientific: Annual Revenues, 2016-H1 2021 (USD Billion)
Table 17.15 Gerresheimer: Annual Revenues, 2016-Q1 2021 (EUR Billion)
Table 17.16 SCHOTT: Annual Revenues, 2016-2020 (EUR Billion)
Table 17.17 Nipro: Annual Revenues, 2016-2020 (JPY Billion)
Table 17.18 Partnerships and Collaborations: Cumulative Year-wise Trend, 2015-2021
Table 17.19 Partnerships and Collaborations: Distribution by Type of Partnership
Table 17.20 Partnerships and Collaborations: Year-wise Trend by Type of Partnership
Table 17.21 Partnerships and Collaborations: Distribution by Type of Fabrication Material Used
Table 17.22 Partnerships and Collaborations: Year-wise Trend by Type of Fabrication Material Used
Table 17.23 Partnerships and Collaborations: Distribution by Sterilization Status
Table 17.24 Partnerships and Collaborations: Year-wise Trend by Sterilization Status
Table 17.25 Partnerships and Collaborations: Distribution by Analysis by Type of Partner
Table 17.26 Partnerships and Collaborations: Year-wise Trend by Analysis by Type of Partner
Table 17.27 Most Active Players: Distribution by Number of Partnerships
Table 17.28 Partnerships and Collaborations: Distribution by Region (Continent-wise)
Table 17.29 Partnerships and Collaborations: Distribution by Region (Country-wise)
Table 17.30 Global Demand for Pharmaceutical Vials, 2021-2030 (Billion Units)
Table 17.31 Global Demand for Pharmaceutical Vials: Distribution by Type of Fabrication Material Used, 2021 and 2030 (Billion Units)
Table 17.32 Global Demand for Pharmaceutical Glass Vials, 2021-2030 (Billion Units)
Table 17.33 Global Demand for Pharmaceutical Plastic Vials, 2021-2030 (Billion Units)
Table 17.34 Global Demand for Pharmaceutical Vials: Distribution by Sterilization Status, 2021 and 2030 (Billion Units)
Table 17.35 Global Demand for Unsterilized Pharmaceutical Vials, 2021-2030 (Billion Units)
Table 17.36 Global Demand for Pre-sterilized Pharmaceutical Vials, 2021-2030 (Billion Units)
Table 17.37 Global Demand for Pharmaceutical Vials: Distribution by Geography, 2021 and 2030
Table 17.38 Demand for Pharmaceutical Vials in North America, 2021-2030 (Billion Units)
Table 17.39 Demand for Pharmaceutical Vials in Europe, 2021-2030 (Billion Units)
Table 17.40 Demand for Pharmaceutical Vials in Asia Pacific, 2021-2030 (Billion Units)
Table 17.41 Demand for Pharmaceutical Vials in Middle East and North Africa, 2021-2030 (Billion Units)
Table 17.42 Demand for Pharmaceutical Vials in Latin America, 2021-2030 (Billion Units)
Table 17.43 Demand for Pharmaceutical Vials in Rest of the World, 2021-2030 (Billion Units)
Table 17.44 Global Pharmaceutical Vials Market, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 17.45 Pharmaceutical Vials: Likely Growth Scenarios
Table 17.46 Pharmaceutical Vials Market, 2021 and 2030: Distribution by Type of Fabrication Material Used, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 17.47 Pharmaceutical Glass Vials Market, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 17.48 Pharmaceutical Plastic Vials Market, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 17.49 Pharmaceutical Vials Market, 2021 and 2030: Distribution by Sterilization Status, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 17.50 Unsterilized Pharmaceutical Vials Market, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 17.51 Pre-sterilized Pharmaceutical Vials Market, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 17.52 Pharmaceutical Vials Market, 2021 and 2030: Distribution by Geography, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 17.53 Pharmaceutical Vials Market in North America, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 17.54 Pharmaceutical Vials Market in Europe, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 17.55 Pharmaceutical Vials Market in Asia-Pacific, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 17.56 Pharmaceutical Vials Market in Middle East and North Africa, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 17.57 Pharmaceutical Vials Market in Latin America, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 17.58 Pharmaceutical Vials Market in Rest of the World, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Billion)

Executive Summary

Chapter 2 is an executive summary of the key insights captured in our report. It offers a high-level view on the current state of the pharmaceutical vials market and its likely evolution in the short-mid term and long term.


Chapter 3 provides a general overview of conventional pharmaceutical packaging and the different types of packaging systems. Further, the chapter features a detailed discussion on pharmaceutical vials, its fabrication material and the different types of caps available. Further, it features a brief discussion on the recent innovations in this domain.


Chapter 4 provides a comprehensive review of the current market landscape of pharmaceutical vials, featuring information on the type of fabrication material used for container (glass and plastic), type of fabrication material used for closure (rubber, plastic and metal), volume of vial (less than 50 ml, 50 ml to 100 ml and more than 100 ml), type of vial cap (screw cap, crimp cap and snap cap), sterilization status (unsterilized and sterilized), type of product (untreated and treated), compatible drug class (biologics and small molecules) and type of formulation stored (liquid, powder and solid). In addition, the chapter includes analysis related to pharmaceutical vial manufacturers, based on various parameters, year of establishment, company size, location of headquarters and key players (in terms of number of products).


Chapter 5 presents a detailed competitiveness analysis of pharmaceutical vial manufacturers , segmented into four categories, namely small (1-50 employees), mid-sized companies (51-500 employees), and large (501-1,000 employees) and very large companies (more than 1,000 employees). Within the peer group, companies were ranked based on various relevant parameters, such as supplier power (based on the experience / expertise of the manufacturer) and key product specifications (type of fabrication material used, type of vial cap, sterilization status, type of product, compatible drug class and type of formulation stored)


Chapter 6 features detailed profiles of the prominent companies that develop pharmaceutical vials in North America. Each company profile features a brief overview of the company, details related to its financials (if available), product portfolio, recent developments and an informed future outlook. 


Chapter 7 features detailed profiles of the prominent companies that develop pharmaceutical vials in Europe. Each company profile features a brief overview of the company, details related to its financials (if available), product portfolio, recent developments and an informed future outlook. 


Chapter 8 features detailed profiles of the prominent companies that develop pharmaceutical vials in Asia Pacific. Each company profile features a brief overview of the company, details related to its financials (if available), product portfolio, recent developments and an informed future outlook. 


Chapter 9 features an elaborate discussion and analysis of the various collaborations and partnerships that have been inked amongst stakeholders in this domain, in the period 2015 – 2021 (till September). Further, the partnership activity in this domain has been analyzed based on various parameters, such as year of partnership, type of partnership model (acquisitions, product / technology integration agreements, supply agreements, asset acquisitions, distribution agreements, product / technology development agreements, product / technology licensing agreements and others), type of fabrication material involved, sterilization status, type of partners and regional distribution of the collaborations.


Chapter 10 discusses the emerging trends in the overall pharmaceutical manufacturing and fill-finish industry. Specifically, it presents the growing demand of personalized therapies, shift towards more flexible packaging, development of modular facilities, upgrading packaging components to enhance drug product safety, increase in partnership activity, and growing adoption of smart packaging solutions.


Chapter 11 provides an overview of the current and future demand for pharmaceutical vials, in the contemporary market. In order to estimate the aforementioned demand, we considered the current supply of pharmaceutical vials and estimated their proportion that are likely to be supplied to the pharmaceutical industry till 2030. We then segregated the total demand across a number of relevant parameters, including type of fabrication material (glass and plastic), sterilization status (pre-sterilized and unsterilized) and geographical regions (North America, Europe, Asia Pacific, Middle East and North Africa, Latin America, and rest of the world).


Chapter 12 presents a comprehensive market forecast analysis, highlighting the future potential of the market till 2030, based on multiple parameters, such as current demand for pharmaceutical vials, likely adoption rates and the estimated price of components. We have segregated the current and upcoming opportunity based on [A] type of fabrication material used (glass and plastic), [B] sterilization status (pre-sterilized and unsterilized) and [C] key geographies (North America, Europe, Asia Pacific, Middle East and North Africa, Latin America and Rest of the world). It is worth mentioning that we adopted a bottom-up approach for this analysis, backing our claims with relevant datapoints and credible inputs from primary research.


Chapter 13 presents a detailed case study on the role of robots in the pharmaceutical manufacturing and fill / finish process, highlighting its benefits and capabilities. It provides a list of the various types of pharmaceutical robots, along with details on their respective manufacturer and applications. Additionally, the chapter features profiles of players that offer robotic equipment for pharmaceutical manufacturing and fill / finish operations, along with information on the key specifications of their respective machinery.  


Chapter 14 provides insights on pre-sterilized / RTU pharmaceutical vials that are currently available, highlighting the pharmaceutical packaging and filling process, and the various limitations associated with the currently used container closure systems. Further, it features an elaborate discussion on the different sterilization techniques used for primary packaging materials and the advantages of RTU containers and closure systems.


Chapter 15 summarizes the overall report. In this chapter, we have provided a list of key takeaways from the report, and expressed our independent opinion related to the research and analysis described in the previous chapters.


Chapter 16 is a collection of interview transcripts of the discussions held with key stakeholders in this market. In this chapter, we have presented the details of interviews held with Julien Marechal (Business Development and Technology Director, Aseptic Technologies) and Konstantin Kazarian (Former Project Manager of Business Development, PYRAMID Laboratories).


Chapter 17 is an appendix, which provides tabulated data and numbers for all the figures provided in the report.


Chapter 18 is an appendix, which contains the list of companies and organizations mentioned in the report.


Companies Mentioned

  • ABB 
  • Abdos Labtech 
  • Acme Vial and Glass
  • ADIT Containers
  • Afton Scientific
  • Agrado
  • ALK Life Science Solutions
  • Allergy Laboratories
  • Amatsigroup (Acquired by Eurofins CDMO)
  • Amber Hydrometers
  • Amcor
  • Anhui Huaxin pharmaceutical glass products
  • Aptar CSP Technologies
  • Aptar Pharma
  • Arab Pharmaceutical Glass
  • ARaymondlife
  • Argos Technologies
  • Aseptic Technologies
  • Automated Systems of Tacoma (AST)
  • Azer Scientific
  • Berkshire Sterile Manufacturing
  • Bespak
  • BioCision
  • Biologix 
  • Bormioli Pharma
  • Borosil
  • Bosch Packaging Technology
  • Cangzhou Four-star Glass
  • Caplugs Evergreen
  • Carewell Glass & Ampoules
  • CELLTREAT Scientific Products
  • Centor
  • CEPI
  • China Lemon Trading
  • Chongqing Zhengchuan Pharmaceutical Packaging 
  • COLANAR
  • Corning
  • Credence MedSystems
  • Crystalgen 
  • CSP Technologies
  • Daikyo Seiko
  • DANYANG XIANGHE PHARMACEUTICAL PACKAGING
  • Dara Pharmaceutical Equipment
  • Datwyler Group
  • DENSO
  • Disposable Lab (Acquired by Amatsigroup)
  • DWK Life Sciences 
  • Empire Industries
  • Enable Injections
  • EZ BioResearch 
  • FANUC America
  • Fedegari Group
  • GEA
  • Gerresheimer
  • Glass Vials
  • Globe Scientific 
  • Goodwin Biotechnology
  • Haldyn Glass Limited (HGL)
  • Heathrow Scientific 
  • HEUFT
  • Hindustan Glass Works
  • Huayi Isotopes Company
  • IMA
  • Insulet
  • ISO Arzneiverpackungen (Acquired by Bormioli Pharma)
  • Jensen Inert Products
  • Jiangsu Chaohua Glasswork
  • Jinan Youlyy Industrial
  • Jinarth Pharma Pack
  • JOTOP GLASS
  • Kapoor Glass
  • Kawasaki Heavy Industries
  • Kimble Chase (Acquired by DWK Life Sciences)
  • Kishore Group
  • Klasspack 
  • KUKA
  • Lab- i-Dositecno  Pharma Technologies
  • Legacy Pharmaceuticals
  • Linuo
  • Lisa Ampoules & Vials
  • Manipal Pharma Pack
  • Marchesini Group
  • MedCision
  • MedicoPack 
  • Medicus Health 
  • Merck
  • Momentive Technologies
  • Muller + Muller (Acquired by DWK Life Sciences)
  • NAFVSM
  • NAIGAI GLASS INDUSTRY
  • Nelson Labs
  • Ningbo Zhengli Pharmaceutical Packaging 
  • Nipro
  • OMRON Industrial Automation
  • OPS Diagnostics
  • Origin Pharma Packaging
  • Pacific Vial Manufacturing
  • Pall Life Sciences
  • Pars Ampoule
  • Pfizer
  • PGP Glass (Previously known as Piramal Glass)
  • Pharmaceutics International
  • Phoenix Glass
  • Prince Sterilization Services
  • PYRAMID Laboratories
  • Radpharm Scientific
  • Raja Tradelinks (RTL)
  • Richland Glass
  • Rigolleau
  • Santa Cruz Biotechnology
  • SCHOTT
  • SCHOTT KAISHA
  • Seiko Epson
  • SENCO Pharma Packaging INDUSTRIES
  • Serum Institute of India
  • SGD Pharma
  • Shandong Pharmaceutical Glass
  • Sharp
  • Simport Scientific
  • SiO2 Materials Science
  • SP Industries (Acquired by Harbour Group)
  • SPL Life Sciences
  • STARLAB 
  • Staubli
  • Sterilab Services
  • Steriline
  • Stevanato Group
  • Stoelzle Glass Group
  • Sumitomo Bakelite
  • Tarsons Products
  • Teja Scientific Glass Works
  • Tekpak
  • Thermo Fisher Scientific
  • Thuringer Pharmaglas
  • Triveni Polymer
  • TrueLine
  • Universal Robots
  • United Pharmacy Partners (UPPI)
  • Vaccines Manufacturing and Innovation Centre
  • Vanrx Pharmasystems
  • Verretubex Industrie
  • Watson-Marlow Fluid Technology Group
  • West Pharmaceutical Services
  • Wheaton Industries (Acquired by DWK Life Sciences)
  • Worldwide Glass Resources
  • Wuxi NEST Biotechnology
  • Yaskawa Electric
  • Ziath

Methodology

 

 

Loading
LOADING...